NZ243580A - Oxy or hydroxy substituted piperidine derivatives and medicaments - Google Patents

Oxy or hydroxy substituted piperidine derivatives and medicaments

Info

Publication number
NZ243580A
NZ243580A NZ243580A NZ24358092A NZ243580A NZ 243580 A NZ243580 A NZ 243580A NZ 243580 A NZ243580 A NZ 243580A NZ 24358092 A NZ24358092 A NZ 24358092A NZ 243580 A NZ243580 A NZ 243580A
Authority
NZ
New Zealand
Prior art keywords
carbons
group
alkyl
hydroxy
hydrogen
Prior art date
Application number
NZ243580A
Other languages
English (en)
Inventor
Willard Mckowan Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ243580A publication Critical patent/NZ243580A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ243580A 1991-07-17 1992-07-16 Oxy or hydroxy substituted piperidine derivatives and medicaments NZ243580A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
NZ243580A true NZ243580A (en) 1994-10-26

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ243580A NZ243580A (en) 1991-07-17 1992-07-16 Oxy or hydroxy substituted piperidine derivatives and medicaments

Country Status (22)

Country Link
EP (1) EP0594729A1 (zh)
JP (1) JP2571904B2 (zh)
KR (1) KR0165003B1 (zh)
CN (1) CN1043759C (zh)
AU (1) AU655840B2 (zh)
BR (1) BR9206272A (zh)
CA (1) CA2113568A1 (zh)
CZ (1) CZ284133B6 (zh)
EG (1) EG20048A (zh)
FI (2) FI940192A (zh)
HU (1) HUT70528A (zh)
IE (1) IE922311A1 (zh)
IL (1) IL102473A (zh)
MX (1) MX9204190A (zh)
NO (1) NO180445C (zh)
NZ (1) NZ243580A (zh)
PL (1) PL169884B1 (zh)
PT (1) PT100689B (zh)
RU (1) RU2065859C1 (zh)
TW (1) TW201732B (zh)
WO (1) WO1993002052A1 (zh)
ZA (1) ZA925306B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
BR9307331A (pt) * 1992-10-30 1999-05-25 Pfizer Compostos neuroprotetores 3,4-dihidro-2(1ho-quinolona
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
WO2000061558A1 (fr) * 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. Remedes pour douleurs neurogenes
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
CA2386441A1 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
SI1379520T1 (sl) 2001-02-23 2006-08-31 Merck & Co Inc N-substituirani nonaril-heterociklicni NMDA/NR2B antagonisti
WO2002080928A1 (en) 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
CA2507509A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
JP2007508288A (ja) * 2003-10-08 2007-04-05 ファイザー株式会社 縮合ラクタム化合物
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
CA2080475C (en) * 1990-05-10 2001-04-17 Bertrand Leo Chenard Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
ZA925306B (en) 1994-01-17
KR0165003B1 (en) 1999-01-15
IL102473A0 (en) 1993-01-14
NO940144D0 (no) 1994-01-14
CN1043759C (zh) 1999-06-23
JPH06504293A (ja) 1994-05-19
TW201732B (zh) 1993-03-11
NO940144L (no) 1994-01-14
IL102473A (en) 1997-07-13
FI940192A0 (fi) 1994-01-14
AU655840B2 (en) 1995-01-12
EG20048A (en) 1997-03-27
BR9206272A (pt) 1995-04-11
CN1068566A (zh) 1993-02-03
FI940192A (fi) 1994-01-14
IE922311A1 (en) 1993-01-27
EP0594729A1 (en) 1994-05-04
PL169884B1 (pl) 1996-09-30
MX9204190A (es) 1993-01-01
RU2065859C1 (ru) 1996-08-27
FI981956A (fi) 1998-09-11
AU2322592A (en) 1993-02-23
PT100689B (pt) 1999-06-30
CZ400892A3 (en) 1994-03-16
NO180445C (no) 1997-04-23
CA2113568A1 (en) 1993-02-04
CZ284133B6 (cs) 1998-08-12
PT100689A (pt) 1993-10-29
WO1993002052A1 (en) 1993-02-04
NO180445B (no) 1997-01-13
HU9400136D0 (en) 1994-05-30
JP2571904B2 (ja) 1997-01-16
HUT70528A (en) 1995-10-30
FI981956A0 (fi) 1998-09-11

Similar Documents

Publication Publication Date Title
NZ243580A (en) Oxy or hydroxy substituted piperidine derivatives and medicaments
KR970005927B1 (ko) 디아릴메틸피페리딘 또는 피페라진의 피리딘 및 피리딘 n-옥사이드 유도체, 이를 함유하는 약제학적 조성물 및 이의 제조방법
US7705003B2 (en) Cyclohexylamides as dopamine D3, D2 and 5-HT1A Antagonists
US20200087248A1 (en) Fluoroallylamine Derivative And Use Thereof
JP2000512296A (ja) セロトニン再取込み阻害
EP0319429B1 (en) 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
US20230056365A1 (en) PROCESS FOR MAKING CRYSTALLINE 2-(3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(CYCLOPROPYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE
EP1025100B1 (de) 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
JPH04261157A (ja) 置換−４−アミノ−３−ピリジノール、その製造法および医薬としてのその使用
EP0612730A1 (en) O-aryl ethers of morphinans
DE3615180C2 (de) Disubstituierte 1,4-Piperazinylderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
US6255322B1 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
CA1266270A (en) Imidazolidinedione derivatives
JPH037280A (ja) 新規ベンゾチオピラニルアミン
EP0639568A1 (en) Piperidine compounds, their preparation and use in the treatment of neurodegenerative disorders
KR100255619B1 (ko) 신규한 피페리딘 유도체 및 이의 제조방법
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
EP4076456B1 (en) Sigma-1 receptor ligands and therapeutic uses thereof
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
CZ8197A3 (en) (1h-indol-4-yl)-piperidine- or tetrahydropyridine ethyl amines and -ethyl carboxamides and pharmaceutical composition containing thereof
AU680562B2 (en) Tricyclic compounds having affinity for the 5-ht1a receptor
JPH0517441A (ja) スピロイソインドリン化合物、その製造方法、それを含有する神経症を治療するための医薬およびそれを製造するための中間体
KR20030097833A (ko) Ｎ-(2,3-디메틸-5,6,7,8-테트라히드로푸로[2,3-ｂ]퀴놀린-4-일)-2-(2-옥소피롤리딘-1-일)아세트아미드의 다형체
EP1105388B1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
JPH05213885A (ja) デカヒドロキノリンの新規な誘導体、それらの製造法、製造中間体、それらの薬剤としての用途及びそれらを含有する組成物